Enveric Biosciences Files 8-K on Feb 21, 2024
Ticker: ENVB · Form: 8-K · Filed: Feb 21, 2024 · CIK: 890821
| Field | Detail |
|---|---|
| Company | Enveric Biosciences, Inc. (ENVB) |
| Form Type | 8-K |
| Filed Date | Feb 21, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, disclosure, corporate-filing
TL;DR
**Enveric Biosciences just dropped an 8-K, signaling new info is out, so keep an eye on the stock!**
AI Summary
Enveric Biosciences, Inc. filed an 8-K on February 21, 2024, under Regulation FD Disclosure and Financial Statements and Exhibits. The filing indicates a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The company, incorporated in Delaware with IRS Employer Identification No. 95-4484725, is headquartered at 4851 Tamiami Trail N, Suite 200, Naples, FL 34103.
Why It Matters
This filing signals that Enveric Biosciences is providing important, non-public information to the market, which could influence investor decisions and the company's stock performance.
Risk Assessment
Risk Level: low — The filing itself is a standard disclosure and does not inherently present a direct risk, though the undisclosed content could.
Key Players & Entities
- Enveric Biosciences, Inc. (company) — Registrant
- Delaware (company) — State of incorporation
- 95-4484725 (dollar_amount) — IRS Employer Identification No.
- February 21, 2024 (date) — Date of earliest event reported
- 4851 Tamiami Trail N, Suite 200, Naples, FL 34103 (company) — Principal executive offices address
FAQ
What is the purpose of this 8-K filing by Enveric Biosciences, Inc.?
The 8-K filing by Enveric Biosciences, Inc. is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, filed under Regulation FD Disclosure and Financial Statements and Exhibits.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on February 21, 2024.
Where are Enveric Biosciences, Inc.'s principal executive offices located?
Enveric Biosciences, Inc.'s principal executive offices are located at 4851 Tamiami Trail N, Suite 200, Naples, FL 34103.
What is the Commission File Number for Enveric Biosciences, Inc.?
The Commission File Number for Enveric Biosciences, Inc. is 001-38286.
What is the state of incorporation for Enveric Biosciences, Inc.?
Enveric Biosciences, Inc. is incorporated in Delaware.
Filing Stats: 591 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-02-21 08:05:30
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share ENVB The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex99-1.htm (EX-99.1) — 40KB
- ex99-1_001.jpg (GRAPHIC) — 8KB
- 0001493152-24-007347.txt ( ) — 269KB
- envb-20240221.xsd (EX-101.SCH) — 3KB
- envb-20240221_lab.xml (EX-101.LAB) — 33KB
- envb-20240221_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 21, 2024 ENVERIC BIOSCIENCES, INC. By: /s/ Joseph Tucker Joseph Tucker Chief Executive Officer